Product Code: GVR-4-68040-263-0
Ayurveda Market Summary
The global ayurveda market size was valued at USD 20.42 billion in 2025 and is expected to reach USD 85.83 billion by 2033, growing at a CAGR of 19.72% from 2026 to 2033. This growth is largely due to the rising prevalence of chronic diseases, increasing awareness of Ayurvedic benefits, and strong adoption and acceptance of Ayurveda across consumer groups.
Growing demand for organic and natural personal care products that use Ayurvedic ingredients such as neem, turmeric and sandalwood is also strengthening industry expansion. A key market trend involves clinical studies that highlight the health benefits of Ayurvedic supplements, which have increased scientific validation, boosted consumer trust and supported wider market uptake. Ayurvedic medicines and treatments are further preferred for their comparatively lower side effects than allopathy. For instance, from September to October 2024, the Journal of Research in Ayurvedic Sciences published an editorial explaining that centuries of empirical Ayurveda should be reassessed using rigorous scientific methods, including experimental, clinical, observational, systematic review and meta-analysis designs. The authors noted that this approach could help address psoriasis, hypertension, obesity, diabetes and musculoskeletal disorders more effectively.
For instance, Turmeric is widely used in various supplements due to its anti-inflammatory properties, which have been validated by research. The market witnessed a surge in demand due to the increasing consumer focus on preventive healthcare and immunity-boosting products during the COVID-19 pandemic. The lockdowns and social distancing measures led to a shift in consumer behavior towards natural and organic products, including Ayurvedic supplements and medicines. Moreover, the growing awareness about the benefits of Ayurveda in managing stress and anxiety levels also contributed to the market growth during COVID-19. Governments around the world are recognizing the potential benefits of Ayurveda and are taking steps to regulate and promote its use.
For instance, in India, the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) has been established to promote traditional medicine and alternative medicine systems. According to the Directorate General of Commercial Intelligence and Statistics (DGCI&S), India's exports of Ayurvedic and herbal products have increased from USD 479.6 million (3,967.4 crores INR) in FY21 to USD 606.2 million (5,014.3 crores INR) in FY23. On the other hand, the import of Ayurvedic and herbal products in India has also increased USD 71.4 million (590.7 crores INR) in FY21 to USD 91.1 million (753.8 crores INR) in FY23, with a compound annual growth rate of 13 %. As a result, India's trade surplus in Ayurvedic and herbal products increased from 408.2 million (3,376.7 crore INR) in FY21 to USD 515.1 million (4,260.5 crore INR) in FY23.
Global Ayurveda Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033s. For this study, Grand View Research has segmented the global Ayurveda market report based on form, application, indications, distribution channel, end use, and region:
- Form Outlook (Revenue, USD Million, 2021 - 2033)
- Herbal
- Mineral
- Herbomineral
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Medical/Therapy
- Personal
- Indications Outlook (Revenue, USD Million, 2021 - 2033)
- GI Tract
- Infectious Diseases
- Skin/Hair
- Respiratory System
- Nervous System
- Cardiovascular System
- Reproductive System
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Direct Sales
- E-sales
- Retail & Institutional Sales
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals & Clinics
- Home Settings
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Middle East & Africa (MEA)
- South Africa
- South Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Form
- 1.2.2. Application
- 1.2.3. Indications
- 1.2.4. Distribution Channel
- 1.2.5. End-use
- 1.2.6. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Form outlook
- 2.2.2. Application outlook
- 2.2.3. Indications outlook
- 2.2.4. Distribution outlook
- 2.2.5. End-use outlook
- 2.3. Competitive Insights
Chapter 3. Ayurveda Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver Analysis
- 3.2.2. Market restraint analysis
- 3.3. Ayurveda Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Ayurveda Market: Form Estimates & Trend Analysis
- 4.1. Form Market Share, 2025 to 2033
- 4.2. Segment Dashboard
- 4.3. Ayurveda Market by Form Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.4.1. Herbal
- 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Mineral
- 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. Herbomineral
- 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Ayurveda Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2025 to 2033
- 5.2. Segment Dashboard
- 5.3. Ayurveda Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.4.1. Medical/Therapy
- 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Personal
- 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Ayurveda Market: Indications Estimates & Trend Analysis
- 6.1. Indications Market Share, 2025 to 2033
- 6.2. Segment Dashboard
- 6.3. Ayurveda Market by Indications Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.4.1. GI Tract
- 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.4.2. Infectious Diseases
- 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.3. Skin/Hair
- 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.4. Respiratory System
- 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.5. Nervous System
- 6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 6.4.6. Cardiovascular System
- 6.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.7. Reproductive System
- 6.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 6.4.8. Others
- 6.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Ayurveda Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Distribution Channel Market Share, 2025 to 2033
- 7.2. Segment Dashboard
- 7.3. Ayurveda Market by Distribution Channel Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.4.1. Direct Sales
- 7.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 7.4.2. E-sales
- 7.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Retail & Institutional Sales
- 7.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Ayurveda Market: End-use Estimates & Trend Analysis
- 8.1. End-use Market Share, 2025 to 2033
- 8.2. Segment Dashboard
- 8.3. Ayurveda Market by End-use Outlook
- 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 8.4.1. Hospitals & Clinics
- 8.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
- 8.4.2. Home Settings
- 8.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Ayurveda Market: Regional Analysis
- 9.1. Ayurveda: Market Share Analysis, 2025 to 2033
- 9.2. Ayurveda: Market Estimates and Forecast, by Region (USD Million)
- 9.3. North America
- 9.3.1. North America Ayurveda Market, 2021 - 2033 (USD Million)
- 9.3.2. U.S.
- 9.3.2.1. U.S. dietary supplements contract manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.3.3. Canada
- 9.3.3.1. Canada Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.3.4. Mexico
- 9.3.4.1. Mexico Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4. Europe
- 9.4.1. Europe Ayurveda Market, 2021 - 2033 (USD Million)
- 9.4.2. UK
- 9.4.2.1. UK Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.3. Germany
- 9.4.3.1. Germany Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.4. France
- 9.4.4.1. France Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.5. Italy
- 9.4.5.1. Italy Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.6. Spain
- 9.4.6.1. Spain Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.7. Denmark
- 9.4.7.1. Denmark Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.8. Sweden
- 9.4.8.1. Sweden Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.4.9. Norway
- 9.4.9.1. Norway Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5. Asia Pacific
- 9.5.1. Asia Pacific Ayurveda Market, 2021 - 2033 (USD Million)
- 9.5.2. Japan
- 9.5.2.1. Japan Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.3. China
- 9.5.3.1. China Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.4. India
- 9.5.4.1. India Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.5. Australia
- 9.5.5.1. Australia Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.6. South Korea
- 9.5.6.1. South Korea Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.5.7. Thailand
- 9.5.7.1. Thailand Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.6. Latin America
- 9.6.1. Latin America Ayurveda Market, 2021 - 2033 (USD Million)
- 9.6.2. Brazil
- 9.6.2.1. Brazil Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.6.3. Argentina
- 9.6.3.1. Argentina Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7. MEA
- 9.7.1. MEA Ayurveda Market, 2021 - 2033 (USD Million)
- 9.7.2. South Africa
- 9.7.2.1. South Africa Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.3. Saudi Arabia
- 9.7.3.1. Saudi Arabia Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.4. UAE
- 9.7.4.1. UAE Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
- 9.7.5. Kuwait
- 9.7.5.1. Kuwait Ayurveda market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company heat map analysis, 2025
- 10.4. Company Profiles
- 10.4.1. Kerala Ayurveda Ltd.
- 10.4.1.1. Company overview
- 10.4.1.2. Financial performance
- 10.4.1.3. Product benchmarking
- 10.4.1.4. Strategic initiatives
- 10.4.2. Patanjali Ayurved Limited
- 10.4.2.1. Company overview
- 10.4.2.2. Financial performance
- 10.4.2.3. Product benchmarking
- 10.4.2.4. Strategic initiatives
- 10.4.3. Dabur Ltd.
- 10.4.3.1. Company overview
- 10.4.3.2. Financial performance
- 10.4.3.3. Product benchmarking
- 10.4.3.4. Strategic initiatives
- 10.4.4. Natreon Inc.
- 10.4.4.1. Company overview
- 10.4.4.2. Financial performance
- 10.4.4.3. Product benchmarking
- 10.4.4.4. Strategic initiatives
- 10.4.5. Vicco Laboratories
- 10.4.5.1. Company overview
- 10.4.5.2. Financial performance
- 10.4.5.3. Product benchmarking
- 10.4.5.4. Strategic initiatives
- 10.4.6. Himalaya Wellness Company
- 10.4.6.1. Company overview
- 10.4.6.2. Financial performance
- 10.4.6.3. Product benchmarking
- 10.4.6.4. Strategic initiatives
- 10.4.7. Emami Group of Companies Pvt Ltd.
- 10.4.7.1. Company overview
- 10.4.7.2. Financial performance
- 10.4.7.3. Product benchmarking
- 10.4.7.4. Strategic initiatives
- 10.4.8. Bio Veda Action Research Co.
- 10.4.8.1. Company overview
- 10.4.8.2. Financial performance
- 10.4.8.3. Product benchmarking
- 10.4.8.4. Strategic initiatives
- 10.4.9. Amrutanjan Health Care Limited
- 10.4.9.1. Company overview
- 10.4.9.2. Financial performance
- 10.4.9.3. Product benchmarking
- 10.4.9.4. Strategic initiatives
- 10.4.10. Baidyanath
- 10.4.10.1. Company overview
- 10.4.10.2. Financial performance
- 10.4.10.3. Product benchmarking
- 10.4.10.4. Strategic initiatives